$ERNA Running Hard! 🚀 Up 29% 🔹 Big biotech momentum after Ernexa highlighted breakthrough preclinical data for ERNA-101 📈 🔹 Lead ovarian cancer candidate sh

$ERNA Running Hard! 🚀 Up 29% 🔹 Big biotech momentum after Ernexa highlighted breakthrough preclinical data for ERNA-101 📈 🔹 Lead ovarian cancer candidate showed 100% survival and complete tumor elimination in preclinical models when combined with PD-1 blockade 🔬 🔹 Company is developing iPSC-de…